MONTREAL, QUEBEC -- (MARKET WIRE) -- 06/20/2006 -- Dr. Pierre Falardeau, President and Chief Executive Officer of Ecopia (TSX: EIA), will be making a presentation tomorrow, June 21 at 11:00 am, at the Orion Securities’ 11th Annual Healthcare Conference, held in Mont-Tremblant, Quebec. During his presentation, Dr. Falardeau will highlight the advancement of Ecopia’s lead anticancer compound, ECO-4601, now in Phase I clinical trial.
